Predict your next investment

Corporation
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
simbionix.com

See what CB Insights has to offer

Total Raised

$12M

Investors Count

9

Deal Terms

3

Simbionix Funding, Simbionix Valuation & Simbionix Revenue

6 Fundings

Simbionix's latest funding round was a Acquired - II for on July 28, 2021.

Simbionix's valuation in August 2014 was $120M.

Simbionix's latest post-money valuation is from July 2021.

Sign up for a free trial to see Simbionix's valuations in July 2021, February 2007 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/28/2021

Acquired - II

$99M

$0.00B

((9.99x))

FY 1234

2

8/30/2014

Acquired

$120M

10

10/22/2008

Series C

$99M

0

2/5/2007

Series B

$99M

$99M

0

5/5/2000

Unattributed VC

$99M

0

Date

7/28/2021

8/30/2014

10/22/2008

2/5/2007

5/5/2000

Round

Acquired - II

Acquired

Series C

Series B

Unattributed VC

Amount

$99M

$99M

$99M

Investors

Valuation

$99M

$120M

$99M

Revenue

$0.00B

((9.99x))

FY 1234

Sources

2

10

0

0

0

Simbionix Deal Terms

3 Deal Terms

Simbionix's deal structure is available for 3 funding rounds, including their Acquired - II from July 28, 2021.

Round

Acquired - II

Acquired

Series B

Funding Date

$99M

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired - II

$99M

$99M

$99M

$99M

Acquired

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

Simbionix Investors

9 Investors

Simbionix has 9 investors. Surgical Science invested in Simbionix's Acquired - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/28/2021

7/28/2021

1
Acquired - II

Corporation

Sweden

00/00/0000

00/00/0000

3D Systems

Subscribe to see more

Corporation

South Carolina

00/00/0000

00/00/0000

Early Stage Partners

Subscribe to see more

Venture Capital

Ohio

00/00/0000

00/00/0000

Western Reserve Partners

Subscribe to see more

Advisory

Ohio

00/00/0000

00/00/0000

River Cities Capital Fund

Subscribe to see more

Subscribe to see more

Venture Capital

Ohio

First funding

7/28/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

7/28/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

3D Systems

Early Stage Partners

Western Reserve Partners

River Cities Capital Fund

Rounds

1
Acquired - II

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Type

Corporation

Corporation

Venture Capital

Advisory

Venture Capital

Location

Sweden

South Carolina

Ohio

Ohio

Ohio

Simbionix Acquisitions

2 Acquisitions

Simbionix acquired 2 companies. Their latest acquisition was GMV ARTHRO VR Product Line on January 30, 2012.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/30/2012

$99M

Acquired Unit

1

1/11/2006

Subscribe to see more

$99M

Subscribe to see more

0

Date

1/30/2012

1/11/2006

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Acquired Unit

Subscribe to see more

Sources

1

0

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.